Priya Patel

Priya Patel

Auto-generated profile, based on publicly available information

Priya Patel

Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Lung Cancer
Verified
Journal Article
Closed access
TKTatsuya Kato
Tatsuya Kato
HWHironobu Wada
Hironobu Wada
PPPriya Patel
Priya Patel
HHHsin-Pei Hu
Hsin-Pei Hu
DLDaiyoon Lee
Daiyoon Lee
KYKazuhiro Yasufuku
Kazuhiro Yasufuku

1 August 2017 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
Hideki UjiieHideki Ujiie
Hideki Ujiie
TKTatsuya Kato
Tatsuya Kato
HHHsin-Pei Hu
Hsin-Pei Hu
PPPriya Patel
Priya Patel
HWHironobu Wada
Hironobu Wada
KYKazuhiro Yasufuku
Kazuhiro Yasufuku

17 May 2017 in Respiration
Verified
Journal Article
Closed access
CTChung Tyan
Chung Tyan
PPPriya Patel
Priya Patel
KCKasia Czarnecka
Kasia Czarnecka
DGDaniela Gompelmann
Daniela Gompelmann
RERalf Eberhardt
Ralf Eberhardt
KYKazuhiro Yasufuku
Kazuhiro Yasufuku
Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a well-established first-line invasive modality for mediastinal lymph node staging in lung cancer patients and in the diagnostic workup of patients with mediastinal adenopathy. With the current 21- and 22-gauge (G) EBUS-TBNA needles, the procedure can be limited by the degree of flexibility in the needle and the size of the lumen in tissue acquisition. Objective: We report our initial experience with a first-generation flexible 19-G EBUS-TBNA (Flex 19G; Olympus Respiratory America, Redmond, WA, USA) needle with regards to efficacy and safety. Methods: The Flex 19G EBUS-TBNA needle was used in 47 selected patients with enlarged hilar and/or mediastinal lymphadenopathy at 3 centers. The standard Olympus EBUS scope with a 2.2-mm working channel was used in all cases. Results: The diagnostic yield of the Flex 19G needle according to clinical cytopathology reports was 89% (42/47). The diagnosis and their respective diagnostic yield with the Flex 19G EBUS-TBNA needle were malignancy 24/27 (89%), sarcoidosis 13/14 (93%), and reactive lymph node hyperplasia 5/6 (83%). The mean short axis of the sampled lymph nodes was 19 ± 9 mm. No complications occurred except for 1 instance of moderate bleeding, which did not require intervention beyond suctioning and subsequently resolved. All 13 patients diagnosed with adenocarcinoma by the 19-G needle had sufficient tissue for genetic testing. Conclusion: EBUS-TBNA using the first-generation Flex 19G needle is feasible and safe with promising diagnostic yield while providing a greater degree of flexion with the Olympus EBUS scope. Additional clinical evaluations are warranted.

1 April 2017 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PPPriya Patel
Priya Patel
HWHironobu Wada
Hironobu Wada
HHHsin-Pei Hu
Hsin-Pei Hu
KHKentaro Hirohashi
Kentaro Hirohashi
TKTatsuya Kato
Tatsuya Kato
KYKazuhiro Yasufuku
Kazuhiro Yasufuku

7 June 2016 in International Journal of Oncology
Verified
Journal Article
Open access
TKTatsuya Kato
Tatsuya Kato
DLDaiyoon Lee
Daiyoon Lee
LWLicun Wu
Licun Wu
PPPriya Patel
Priya Patel
AYAhn Jin Young
Ahn Jin Young
KYKazuhiro Yasufuku
Kazuhiro Yasufuku
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

1 March 2017 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
Hideki UjiieHideki Ujiie
Hideki Ujiie
TKTatsuya Kato
Tatsuya Kato
HHHsin-Pei Hu
Hsin-Pei Hu
SHSuhaib Hasan
Suhaib Hasan
PPPriya Patel
Priya Patel
KYKazuhiro Yasufuku
Kazuhiro Yasufuku